HandyLab is dedicated to the development, manufacture and sale of novel molecular diagnostic products. HandyLab’s proprietary platform reduces the time, cost and complexity of testing while improving the quality of results. Using patented real time microfluidic PCR technology, HandyLab’s products are positioned to decentralize nucleic acid testing. HandyLab is an Ann Arbor, Michigan based company. Additional information about the company can be found on the internet at www.handylab.com, or by calling 1-866-Handy Lab (1-866-426-3952).


Becton, Dickinson and Co., a New Jersey-based global medical devices manufacturer, is closing its Pittsfield Township office after paying $275 million last year for the University of Michigan spinoff firm HandyLab, a spokeswoman confirmed this afternoon.

  • Acqusition, 2009

Franklin Lakes, NJ (November 20, 2009) – BD (Becton, Dickinson and Company) (NYSE:BDX) today announced the completion of its acquisition of HandyLab, Inc., an Ann Arbor, Michigan-based company that develops and manufactures molecular diagnostic assays and automation platforms.


News references